VKTX Viking Therapeutics, Inc.
$31.98▼ -0.47%
Healthcare
Other
After hours
$32.13▲ +0.47%
Sep 11, 7:59 PM ET
Volume 2.20M
Avg Volume (10D) 1.80M
Key Metrics & Fundamentals
Market Cap
$3.73B
P/E Ratio
–
Div Yield
–%
52W Range
22.96 - 43.15
% vs 50 MA
-8.51%
% vs 200 MA
-4.37%
RSI-14
41.5
MACD Histogram
-0.1200
Beta (1Y vs SPY)
1.19
Free Cash Flow
-$125.17M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$132.47M
COGS
–
Operating Exp
$132.60M
Operating Income
-$132.60M
EBIT
-$132.60M
Pretax Income
-$128.02M
Net Income
-$128.02M
EPS (Diluted)
-1.10
Price & Volume History
Loading chart…
Recent News
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?
Zacks · Sep 11, 2026 1:30 PM
Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors
Zacks · Sep 10, 2026 9:45 PM
Axsome Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool · Sep 10, 2026 5:30 PM
Analysts Have a $92 Target on Viking Therapeutics. Here's What Has to Go Right to Get There.
Motley Fool · Sep 10, 2026 10:30 AM
Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks · Sep 9, 2026 9:50 PM
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case.
Motley Fool · Sep 6, 2026 12:20 AM
Is Viking Therapeutics (VKTX) Stock Fully Priced After A 411% Run?
Simply Wall St. · Sep 4, 2026 8:10 PM
Why Is Mirum Pharmaceuticals (MIRM) Up 6.9% Since Last Earnings Report?
Zacks · Sep 4, 2026 3:30 PM
Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know
Zacks · Sep 3, 2026 9:45 PM
3 Wall Street Analysts Think Viking Therapeutics Stock Will Roughly Triple Over the Next 12 Months. Here's Why I Think They're Wrong
Motley Fool · Sep 3, 2026 8:50 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See VKTX's money flow as a full page
Social Sentiment
Avg +0.46 · 47 posts
DDNewsDiscussionVKTX- Is vk-2735 , the next glp-1 candidate in a Phase 3 trial, going to challenge tirzepatide and semaglutide?
r/wallstreetbets · Feb 14, 2026
The post expresses optimism about VK-2735's potential to compete with GLP-1 drugs, and the author owns shares.
positive
+0.60
NewsTradeDiscussionViking therapeutics (VKTX) moonshot
r/wallstreetbets · Feb 9, 2026
The author expresses a strong bullish sentiment, indicating a belief in significant price increases.
positive
+0.80
Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war with Eli Lilly
r/stocks · Jan 6, 2026
VKTX's stock price dropped significantly following the launch, indicating negative investor sentiment.
negative
-0.60
VKTX strong comeback
r/stocks · Nov 12, 2025
The post expresses optimism regarding VKTX's comeback and potential, driven by positive trial data and takeover speculation.
positive
+0.60
NewsDiscussionTradeNovo Nordisk hijacks Pfizer with bid for US biotech Metsera
r/wallstreetbets · Oct 30, 2025
The post directly states 'Novo needs VKTX', demonstrating a strong bullish sentiment.
very_positive
+0.90
Page 1 of 10 (47 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.